OppenheimerFunds’s AstraZeneca AZN Stock Holding History

OppenheimerFunds’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$166M	Buy	2,052,645 +1,201,960	+141%	+$94.7M	0.21%	111
2018 Q4	$64.6M	Buy	850,685 +594,695	+232%	+$46.4M	0.09%	217
2018 Q3	$20.3M	Buy	255,990 +189,368	+284%	+$14.3M	0.02%	581
2018 Q2	$4.68M	Hold	66,622	–	–	0.01%	794
2018 Q1	$4.66M	Buy	66,622 +15	+0%	+$1.04K	0.01%	772
2017 Q4	$4.62M	Sell	66,607 -2,578	-4%	-$174K	0.01%	816
2017 Q3	$4.69M	Buy	69,185 +16,000	+30%	+$1.01M	0.01%	822
2017 Q2	$3.63M	Buy	+53,185	New	+$3.47M	﹤0.01%	846
2017 Q1	–	Sell	-38,231	Closed	-$2.09M	–	1861
2016 Q4	$2.09M	Buy	+38,231	New	+$2.17M	﹤0.01%	916

Other funds holding AZN

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return